A new method of UPLC-MS/MS for determination of chlorogenic acid in human plasma and urine.
Chlorogenic acid (CA) is well known for its various biological activities. Here, a clinical study was performed in patients with advanced malignant cancer to explore its therapeutic effects. We aimed to develop a method to quantify CA in human plasma and urine to assist the clinical pharmacokinetic study. The ultra-performance liquid-chromatography coupled with a triple quadruple mass spectrometer was used to separate and detect CA, with puerarin serving as the internal standard. The method presents an excellent linearity ranging from 5 to 2000 ng/mL for plasma analysis and 50 to 20000 ng/mL for urine analysis. Intra- and inter-day precision and accuracy were both less than 15% for plasma and urine. These results showed that the novel UPLC method was robust and sensitive, and fulfilled the requirements for a clinical pharmacokinetic study of CA in patients with advanced cancer.